GSA CAPITAL PARTNERS LLP - POSEIDA THERAPEUTICS INC ownership

POSEIDA THERAPEUTICS INC's ticker is PSTX and the CUSIP is 73730P108. A total of 90 filers reported holding POSEIDA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.

Quarter-by-quarter ownership
GSA CAPITAL PARTNERS LLP ownership history of POSEIDA THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$130
-20.7%
74,040
+38.7%
0.01%
-18.8%
Q1 2023$164
-67.6%
53,399
-44.1%
0.02%
-74.6%
Q4 2022$506
-99.9%
95,469
+12.7%
0.06%
-12.5%
Q4 2021$577,00084,7010.07%
Other shareholders
POSEIDA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,043,267$7,605,0001.52%
Privium Fund Management (UK) Ltd 48,470$353,0000.38%
Pentwater Capital Management LP 4,967,227$36,211,0000.37%
J. Goldman & Co LP 301,391$2,197,0000.11%
Perceptive Advisors 787,745$5,743,0000.08%
KNOTT DAVID M 29,566$216,0000.08%
Virtus ETF Advisers LLC 23,082$168,0000.07%
Altium Capital Management LP 32,238$235,0000.06%
Advisory Services Network, LLC 268,290$1,956,0000.06%
MCF Advisors LLC 66,185$482,0000.05%
View complete list of POSEIDA THERAPEUTICS INC shareholders